_2020091018165303jzv.jpg "Decoding The World Of ETF")
-
My Account
My Account
BSE Live
Dec 01, 16:00Prev. Close
363.00
Open Price
375.00
Bid Price (Qty.)
369.55 (37)
Offer Price (Qty.)
372.00 (200)
NSE Live
Dec 01, 15:49Prev. Close
363.25
Open Price
366.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
369.95 (144)
| Nine Months Results of RPG Life Sciences (in Rs. Cr.) | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 | |
| Net Sales/Income from operations | 286.90 | 261.36 | 260.49 | 226.15 | 205.72 | |
| Other Operating Income | -- | -- | -- | 6.41 | 3.30 | |
| Total Income From Operations | 286.90 | 261.36 | 260.49 | 232.56 | 209.02 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 56.96 | 41.64 | 50.43 | 44.73 | 47.16 | |
| Purchase of Traded Goods | 49.34 | 33.04 | 35.71 | 45.85 | 24.00 | |
| Increase/Decrease in Stocks | -9.06 | 12.12 | 1.83 | -9.85 | -2.16 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 72.22 | 70.02 | 65.27 | 56.53 | 55.91 | |
| Depreciation | 12.24 | 11.38 | 10.66 | 8.33 | 7.64 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | 0.01 | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 70.79 | 77.53 | 78.31 | 71.19 | 65.62 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 34.41 | 15.63 | 18.28 | 15.78 | 10.84 | |
| Other Income | 0.35 | 0.38 | 0.66 | 0.47 | 0.77 | |
| P/L Before Int., Excpt. Items & Tax | 34.76 | 16.01 | 18.94 | 16.25 | 11.61 | |
| Interest | 1.45 | 3.08 | 2.97 | 1.55 | 2.24 | |
| P/L Before Exceptional Items & Tax | 33.31 | 12.93 | 15.97 | 14.70 | 9.37 | |
| Exceptional Items | -- | -- | -- | 7.38 | -- | |
| P/L Before Tax | 33.31 | 12.93 | 15.97 | 22.08 | 9.37 | |
| Tax | 7.28 | 3.66 | 3.77 | 1.41 | -- | |
| P/L After Tax from Ordinary Activities | 26.03 | 9.27 | 12.20 | 20.67 | 9.37 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 26.03 | 9.27 | 12.20 | 20.67 | 9.37 | |
| Equity Share Capital | 13.23 | 13.23 | 13.23 | 13.23 | 13.23 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 15.74 | 5.61 | 7.38 | 12.50 | 5.67 | |
| Diluted EPS | 15.74 | 5.61 | 7.38 | 12.50 | 5.67 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 15.74 | 5.61 | 7.38 | 12.50 | 5.67 | |
| Diluted EPS. | 15.74 | 5.61 | 7.38 | 12.50 | 5.67 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- |
02.11.2020
RPG Life Sciences shifts gears, bets on chronic drugs to expand sales, profits
03.08.2020
RPG Life Standalone June 2020 Net Sales at Rs 91.65 crore, down 2.54% Y-o-Y
30.12.2019
Breakout buys: SBI, Hindalco among 10 stocks to consider for January series
30.07.2019
RPG Life Sciences profit jumps four-fold led by domestic formulation biz growth
03.08.2020
RPG Life Standalone June 2020 Net Sales at Rs 91.65 crore, down 2.54% Y-o-Y
30.07.2019
RPG Life Standalone June 2019 Net Sales at Rs 94.04 crore, up 17.71% Y-o-Y
30.04.2019
RPG Life Standalone March 2019 Net Sales at Rs 68.80 crore, down 17.57% Y-o-Y
06.02.2019
RPG Life Standalone December 2018 Net Sales at Rs 90.97 crore, down 4.9% Y-o-Y
